Non-Royalty Sublicense Income. In partial consideration for the rights and licenses granted hereunder, Licensee will pay Harvard an amount equal to [**] percent ([**]%) of all Non-Royalty Sublicense Income.
Non-Royalty Sublicense Income. Licensee will pay Elkurt an amount equal to (a) [####] of all Non-Royalty Sublicense Income for any Sublicense executed prior to the First Commercial Sale and (b) [####] of all Non-Royalty Sublicense Income for any Sublicense executed after the First Commercial Sale.
Non-Royalty Sublicense Income. As partial consideration for the licenses granted hereunder. Licensee shall pay Harvard an amount equal to [* * *] of all Non-Royalty Sublicense Income. Notwithstanding the foregoing, if a Sublicense is part of a transaction in which [* * *] to be attributed to the Sublicense as part of the overall transaction. In such event, the amount payable to Harvard under this Section 4.6 with respect to Non-Royalty Sublicense Income received in connection with such transaction shall be determined by the following equation:
Non-Royalty Sublicense Income. Bayer shall pay Compugen the following amounts on Non-Royalty Sublicense Income:
Non-Royalty Sublicense Income. In the event Licensee has granted options or sublicenses to Sublicensees under this Agreement, Licensee shall pay CMCC the following percentages on payments it receives from Sublicensee (other than royalties based on Net Sales) including but not limited to sublicense issue fees, any lump sum payments, option fees, milestone payments, technology transfer payments or other similar fees, payments, and cash consideration, but excluding, in any event, equity issuances, payments for patent prosecution or enforcement of the Patent Rights, research and development payments or payments for capital equipment expenses (“Non-Royalty Sublicense Income”):
Non-Royalty Sublicense Income. A Ten Percent (10%) share of all Non-Royalty Sublicense Income. Non-Royalty Sublicense Income payments pursuant to this Section 4.1(e) shall by due immediately and paid within thirty (30) days after receipt of payment by Licensee from sublicense.
Non-Royalty Sublicense Income. [Licensee will pay Harvard nonrefundable, non-recoverable and non-creditable amounts equal to Royalty Sublicense Income.] percent ( %) of all Non- [Tiered Alternative:][Licensee will pay Harvard a percentage of Non-Royalty Sublicense Income received by Licensee or its Affiliate in connection with a Sublicense as follows:
Non-Royalty Sublicense Income. (a) On a Sublicensee-by-Sublicensee basis, CRISPR will, in addition to Development and Commercial Milestones in accordance with Section 5.4 and royalties on Net Sales in accordance with Section 5.5, pay CureVac the percentage set forth below of Non-Royalty Sublicense Income received by CRISPR or its Affiliates in accordance with the following table: Stage at which sublicense is granted by % of Non-Royalty % of Non-Royalty Payable to CureVac for from Casebia Payable Such Sublicense (“Full to CureVac for Such Sublicense Rate”) Sublicense (“Reduced Sublicense Rate”) [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] In the event CRISPR receives the Non-Royalty Sublicense Income at the Reduced Sublicense Rate from Casebia, CRISPR shall pay the difference to the Non-Royalty Sublicense Income at the Full Sublicense Rate once and if the Third Party who obtained the sublicense from Casebia grants a sub-sublicense to another Third Party. For illustration purposes: If Casebia receives an upfront payment from its Sublicensee in the amount of [*****] US dollars (US$ [*****]), CRISPR shall pay [*****] US dollars (US$ [*****] rather than [*****] US dollars (US$ [*****]) to CureVac. The difference between the Non-Royalty Sublicense Income calculated at the Full Sublicense Rate and the Non-Royalty Sublicense Income calculated at the Reduced Sublicense Rate [*****] shall be paid if and once Casebia’s Sublicensee grants a sub-sublicense to a Third Party and makes a first upfront or milestone payment to Casebia. For clarity, no license or sublicenses between CRISPR and any of its Affiliates shall give rise to any payments under this Agreement.
Non-Royalty Sublicense Income. If Mxxxxxxx enters into any agreement with a Third Party that includes a worldwide, exclusive (including with respect to Mxxxxxxx) sublicense (“Worldwide Sublicense”) under all or substantially all of the Licensed IP Rights to develop, make, have made, use, offer for sale, sell and import all Products for use in the Field of Use, Mxxxxxxx shall give prompt written notice to TGV thereof. Within thirty (30) days after receipt of such written notice from Mxxxxxxx, TGV shall have the right, at its option but only in the event permitted by applicable law or regulation, to exchange the Mxxxxxxx Shares for an additional sublicense royalty stream as set forth below by giving express written notice to Mxxxxxxx thereof. If TGV timely exercises its such option as set forth above, then (a) within ten (10) days after the date of such notice, TGV shall duly convey, transfer and assign to Mxxxxxxx all right, title and interest in and to shares of common stock of Mxxxxxxx equal to the number of the Mxxxxxxx Shares (together with any and all new, substituted or additional securities issued in respect of the Mxxxxxxx Shares upon any stock split, stock dividend, recapitalization, merger, consolidation or similar events), free and clear of all encumbrances, liens and claims, including by duly executing and delivery such assignments and other instruments and agreements as reasonably requested by Mxxxxxxx, and (b) Mxxxxxxx shall, within fifty (50) days after the receipt of any Non-Royalty Sublicense Income, provide written notice thereof to TGV and remit to TGV an amount equal to five percent (5%) of such Non-Royalty Sublicense Income. For purposes of this Section 4.7, the term “Worldwide Sublicense” shall mean an exclusive sublicense or series of exclusive sublicenses executed on the same date with the same Third Party where the United States is included within the sublicensed territory. TGV shall have the right to audit the records of Mxxxxxxx to confirm the accuracy of the amount of the Non-Royalty Sublicense Income pursuant to the terms of Section 4.6.
Non-Royalty Sublicense Income. As partial consideration for the license granted hereunder, Licensee shall pay TRDF and amount equal to twenty percent (20%) of all Non-Royalty Sublicense Income.
